AstraZeneca Launches DUTOPROL
AstraZeneca (NYSE: AZN) today announced the availability of DUTOPROL™ (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL® (metoprolol succinate) plus a low-dose diuretic (also known as a water pill) that provides proven blood pressure lowering at 24 hours.1,2
“One in three US adults have high blood pressure, and of these patients whom are treated, approximately 36% remain uncontrolled,” said Steve Davis, Executive Director, Foundation Brands, AstraZeneca.4 “DUTOPROL may provide another treatment option for patients with hypertension. We have launched DUTOPROL so patients now have the option to receive a branded combination medicine, in a convenient, once-a-day tablet.”
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.